A Platform Technology

Alma‘s platform technology promises to yield a versatile pipeline: With a therapy that restores immune balance, it has the potential to address a broad spectrum of autoimmune diseases.

Inflammatory Bowel Disease (IBD)

Spondyloarthritis

Ocular Inflammatory Diseases

Proof of Concept

Preclinical Development

IND Enabling Studies

Phase I/IIa

Inflammatory Bowel Disease (IBD)
Spondyloarthritis
Ocular Inflammatory Diseases